BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24986606)

  • 1. Eosinophil cell lines.
    Ishihara K
    Methods Mol Biol; 2014; 1178():45-51. PubMed ID: 24986606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():77-82. PubMed ID: 15947489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors.
    Kaneko M; Ishihara K; Takahashi A; Hong J; Hirasawa N; Zee O; Ohuchi K
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():28-32. PubMed ID: 17541273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors.
    Ishihara K; Kaneko M; Kitamura H; Takahashi A; Hong JJ; Seyama T; Iida K; Wada H; Hirasawa N; Ohuchi K
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():7-10. PubMed ID: 18504399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of eosinophils in allergic inflammation].
    Ishihara K
    Yakugaku Zasshi; 2005 Sep; 125(9):717-23. PubMed ID: 16141691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
    Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
    Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells.
    Hong J; Ishihara K; Yamaki K; Hiraizumi K; Ohno T; Ahn JW; Zee O; Ohuchi K
    Cancer Lett; 2003 Jan; 189(2):197-206. PubMed ID: 12490313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
    McBain JA; Eastman A; Nobel CS; Mueller GC
    Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of adipocyte differentiation by histone deacetylase inhibitors.
    Kim SN; Choi HY; Kim YK
    Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
    Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
    Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
    Gunin AG; Kapitova IN; Suslonova NV
    J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
    Witt O; Monkemeyer S; Rönndahl G; Erdlenbruch B; Reinhardt D; Kanbach K; Pekrun A
    Blood; 2003 Mar; 101(5):2001-7. PubMed ID: 12393499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.
    Arts J; Lansink M; Grimbergen J; Toet KH; Kooistra T
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):171-6. PubMed ID: 7646441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
    Kumar KS; Sonnemann J; Beck JF
    Oncol Rep; 2006 Nov; 16(5):1047-52. PubMed ID: 17016591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.